Intellipharmaceutics International Inc V.IPCI.H

Alternate Symbol(s): IPCIQ

Healthcare

Intellipharmaceutics International Inc. is a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs. Its Hypermatrix technology is a multidimensional controlled-release drug delivery platform that can be applied to a range of existing and new pharmaceuticals. It has developed several drug delivery systems based on this technology platform, with a pipeline of products in various stages of development. The Company has ANDA and NDA 505(b)(2) drug product candidates in its development pipeline. These include the Company’s abuse-deterrent oxycodone hydrochloride extended-release formulation (Oxycodone ER) based on its proprietary nPODDDS novel Point of Divergence Drug Delivery System (for which an NDA has been filed with the FDA), and Regabatin XR (pregabalin extended-release capsules). Its product portfolio includes both new products and controlled-release generic products.

TSXV:IPCI.H - Post by User

Intellipharmaceutics International Inc > FDA APPROVAL

<< Previous

Bullboard Posts

Next >>

Post by Fonzieeon Jan 02, 2020 12:22pm

416 Views

Post# 30511340

FDA APPROVAL

When this stock gets fda approval on the 15th it will be worth close to $25 a share. Yes $25 a share. Even Danny Deadlock states ; "However,these are microcap lottery stocks.Should this drug get FDA approval, it could be worth several hundred million dollars to the valuation of IPCI. Even $100M would add $5 per share because there are only 23M shares out." Buy now while you still can afford it.

<< Previous

Bullboard Posts

Next >>

From now on, dynaCERT instead of Bitcoin or NVIDIA?